10X Genomics Inc
NASDAQ:TXG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
S
|
Sandisk Corp
NASDAQ:SNDK
|
US |
|
I
|
International Flavors & Fragrances Inc
DUS:IFF
|
US |
|
B
|
Buckle Inc
F:BK2
|
US |
|
L
|
Lynas Rare Earths Ltd
F:LYI
|
MY |
|
Itochu Corp
F:IOC0
|
JP |
|
Snam SpA
MIL:SRG
|
IT |
|
Globant SA
NYSE:GLOB
|
LU |
|
L
|
Lonza Group AG
XMUN:LO3
|
CH |
|
M
|
Mena Transport PCL
SET:MENA
|
TH |
|
Mercedes-Benz Group AG
F:DAII
|
DE |
|
C
|
Coca-Cola Co
XHAM:CCC3
|
US |
|
Nomura Holdings Inc
NYSE:NMR
|
JP |
|
W
|
Waters Corp
XMUN:WAZ
|
US |
|
Clemondo Group AB (publ)
STO:CLEM
|
SE |
|
N
|
Nucor Corp
SWB:NUO
|
US |
|
Vodafone Group PLC
LSE:VOD
|
UK |
|
NVIDIA Corp
NASDAQ:NVDA
|
US |
|
T
|
T Rowe Price Group Inc
XMUN:TR1
|
US |
|
E
|
Empire Metals Ltd
F:NOGN
|
UK |
|
C
|
Citigroup Inc
SWB:TRVC
|
US |
|
Liontrust Asset Management PLC
LSE:LIO
|
UK |
|
Legrand SA
PAR:LR
|
FR |
|
Royal Bank of Canada
TSX:RY
|
CA |
Bankruptcy Probability
10X Genomics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
10X Genomics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
10X Genomics Inc
NASDAQ:TXG
|
11.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
252.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
159.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
479.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
49.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
40.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
64T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
44.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
43.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Illumina Inc
NASDAQ:ILMN
|
41.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Mettler-toledo International Inc
NYSE:MTD
|
33.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
10X Genomics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, 10X Genomics Inc has no debt.
You can find a full breakdown on its Balance Sheet.